Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience.
Fernanda BuenoAnabella SmuleverInés CalifanoJorgelina GuerraAndrés Del GreccoJuan Manuel CarreraRaúl GiglioManglio RizzoAlejo LinguaAna VoogdMaría Del Carmen NegueruelaErika AbelleiraFabián PitoiaPublished in: Endocrine (2023)
This report contributes to illustrate the feasibility and effectiveness of D-T treatment in five patients with loco-regionally advanced and metastatic BRAF V600E-mutated ATC in a real-life setting. A multidisciplinary approach and rapid molecular-tailored testing are essential to begin this therapeutic option.